Targeting Mononuclear Phagocytes to Treat COVID-19
Coronavirus disease 2019 (COVID-19) and its etiological agent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have caused considerable illness and death worldwide. The innate immune system seems to play a principal in the disease, as a hallmark of severe COVID-19 is excessive inflammati...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/77494 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Targeting Mononuclear Phagocytes to Treat COVID-19
- The Role of Non-Phagocytic Cells in Mycobacterial Infections
- Phagocytes as Key Players: Unveiling Cell-Death Patterns Induced by Vaccines in Combating Infectious Diseases
- New Perspective and Applications of Homeopathy in Treating COVID-19 Symptoms
- Macrophages as a Target for Treating Diabetic Foot Ulcers
- Targeting T Cells to Treat Trypanosoma cruzi-Induced Myocarditis
- Unraveling the Significance of Phage-Derived Enzymes for Treating Secondary Bacterial Infections among COVID-19 Patients